BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 4646)

  • 1. [Effect of berotek in patients with chronic obstructive lung diseases].
    Makel'skiĭ VV
    Klin Med (Mosk); 1975 Dec; 53(12):80-2. PubMed ID: 4646
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evaluation of the effectiveness of bricanyl].
    Ubaĭdullaev AM; Makhmudova DKh; Iakimova MA; Islamkhodzhaev PS
    Ter Arkh; 1980; 52(11):130-2. PubMed ID: 6110247
    [No Abstract]   [Full Text] [Related]  

  • 3. [Physical work capacity of patients with bronchial asthma after treatment with bronchodilator agent, berotek].
    Eremina SS; Solomonova LN
    Sov Med; 1975 Aug; (8):141-2. PubMed ID: 793
    [No Abstract]   [Full Text] [Related]  

  • 4. [The therapeutic potentials of Berotec-100 in bronchial asthma patients].
    Emel'ianov AV; Shevelev SE; Shubin SA; Sinitsina TM; Fedoseev GB
    Klin Med (Mosk); 1998; 76(7):38-9. PubMed ID: 9742777
    [No Abstract]   [Full Text] [Related]  

  • 5. [Drug tolerance in asthmatic patients treated with beta adrenergic drugs].
    Herjavecz I; Böszórményi ; Nagy G; Szeitz A; Debreczeni L
    Orv Hetil; 1985 Sep; 126(39):2401-4, 2407. PubMed ID: 2864677
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of a patch formulation of tulobuterol on cough scores and PEF in patients with cough variant asthma].
    Fujimori K; Suzuki E; Gejyo F
    Arerugi; 2000 Aug; 49(8):658-61. PubMed ID: 11021018
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparison of the bronchodilating effects of five beta-adrenergic stimulants administered by inhalation to patients with bronchial asthma].
    Kokubu H
    Arerugi; 1993 Jun; 42(6):699-705. PubMed ID: 8102230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salmeterol for the treatment of asthma.
    Weinberger M
    Ann Allergy Asthma Immunol; 1995 Sep; 75(3):209-11. PubMed ID: 7552921
    [No Abstract]   [Full Text] [Related]  

  • 9. Indacaterol Novartis/skyePharma.
    Currie GP
    Curr Opin Investig Drugs; 2006 May; 7(5):457-63. PubMed ID: 16729723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A new aerosol adrenergic bronchodilator, procaterol. Comparative study of salbutamol and procaterol].
    Morin D; Milot J; Turcotte H; Boulet LP
    Union Med Can; 1987 Apr; 116(4):215-8. PubMed ID: 2885957
    [No Abstract]   [Full Text] [Related]  

  • 11. Adrenergic agonists and bronchodilator aerosol therapy in asthma.
    Shim C
    Clin Chest Med; 1984 Dec; 5(4):659-68. PubMed ID: 6151440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence based answers--is salmeterol safe in asthma?
    Spurling G; Doust J
    Aust Fam Physician; 2006 Aug; 35(8):625-6. PubMed ID: 16894440
    [No Abstract]   [Full Text] [Related]  

  • 13. Beta-agonists, beta-blockers and obstructive airway disease.
    Madalena Esteves M
    Eur Ann Allergy Clin Immunol; 2005 Dec; 37(10):375-9. PubMed ID: 16528900
    [No Abstract]   [Full Text] [Related]  

  • 14. Asthma and regular beta agonist therapy.
    O'Donnell TV; Rea HH; Crane J; Town IG; Watson A
    N Z Med J; 1991 Jan; 104(904):16. PubMed ID: 1672558
    [No Abstract]   [Full Text] [Related]  

  • 15. Salmeterol.
    Med Lett Drugs Ther; 1994 Apr; 36(921):37-9. PubMed ID: 7909139
    [No Abstract]   [Full Text] [Related]  

  • 16. [New beta-adrenergic receptor stimulators in the symptomatic treatment of asthma and chronic obstructive bronchial diseases].
    Van Der Straeten M; Lamont H; Pauwels R; Tasson J
    Acta Tuberc Pneumol Belg; 1974; 65(3-4):384-94. PubMed ID: 4156900
    [No Abstract]   [Full Text] [Related]  

  • 17. [Beta2 agonists and anticholinergics. Inhalation therapy in acute deterioriation of asthma and chronic obstructive pulmonary disease].
    Ringbaek TJ; Phanareth K; Lange P
    Ugeskr Laeger; 1996 Oct; 158(42):5957-62. PubMed ID: 8928288
    [No Abstract]   [Full Text] [Related]  

  • 18. [Efficacy of salmeterol in patients with allergic bronchial asthma].
    Pacor ML; Biasi D; Cortina P; Maleknia T; Lunardi C
    Clin Ter; 1994 Aug; 145(8):131-4. PubMed ID: 7955958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [How risky are beta-2 mimetics?].
    Paukstadt W
    MMW Fortschr Med; 2006 Aug; 148(33-34):10. PubMed ID: 16981376
    [No Abstract]   [Full Text] [Related]  

  • 20. [Duration of the therapeutic effect of a beta 2 stimulant (procaterol hydrochloride) in patients with asthmatiform bronchopathies].
    Cammarata A; Mazzarella G; Grella E; Liccardo G
    Arch Monaldi Mal Torace; 1988; 43(2):131-40. PubMed ID: 2908377
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.